Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin

US Patent 10987370 · Granted Apr 27, 2021

Assignee

Inventors

View full patent text on Google Patents →